Abstract
Since the dawn of mankind, there has been cancer. From so simple a beginning, cancer, in all of its forms and complexities, has become the second leading cause of death in the United States. It is responsible for one out of four deaths, and totaled 549,838 (23% of all deaths) for the year 1999 (1). It is estimated that it will surpass cardiovascular disease as the number one killer by the year 2015. For melanoma, the incidence is increasing at an alarming rate. For the year 2002, new melanoma cases will be diagnosed in 53,600 individuals, claiming 7,400 lives (1). We have had limited success in the treatment of advanced stage melanoma with most patients succumbing to death within the first year of diagnosis.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Smith, R. A., Cokkinides, V., von Eschenbach, A. C. (2002) Cancer Statistics, 2002: Progress or cause for concern? CA Cancer J. Clin. 52, 6ā8.
Cormier, J. N., Hijazi, Y. M., Abati, A., et al. (1998) Heterogeneous expression of melanoma-associated antigens (MAA) and HLA-A2 in metastatic melanoma in vivo. Int. J. Cancer 75, 517ā524.
Riker, A. I., Panelli, M. C., Kammula, U. S., et al. (1999) Development and characterization of melanoma cell lines established by fine-needle aspiration biopsy: Advances in the monitoring of patients with metastatic melanoma. Cancer Det. and Prev. 23, 387ā396.
Luyten, G. P., Naus, N. C., Mooy, C. M., et al. (1996) Establishment and characterization of primary and metastatic uveal melanoma cell lines. Int. J. Cancer 66, 380ā387.
McNamara, M., Kennedy S. M. (1997) Successful establishment of uveal and conjunctival melanoma in vitro. In vitro Cell Dev. Biol. Anim. 33, 236ā239.
Behm, F. G., OāDowd, G. J., Frable, W. J. (1984) Fine-needle aspiration effects on benign lymph node histology. Am. J. Clin. Pathol. 82, 195ā198.
Ljung, B. M., Chew, K., Deng, G., Matsumura, K., Waldman, F. M., and Smith, H. (1994) Fine needle aspiration techniques for the characterization of breast cancers. Cancer 74, 1000ā1005.
Cormier, J. N., Panelli, M. C., Hackett, J. A., et al. (1999) Natural variation of the expression of HLA and endogenous antigen modulates CTL recognition in an in vitro melanoma model. Int. J. Cancer 80, 781ā790.
Marincola, F. M., Hijazi, Y. M., Fetsch, P., et al. (1996) Analysis of expression of the melanoma-associated MART-1 and gp100 in metastatic melanoma cell lines and in in-situ lesions. J. Immunother. 19, 192ā205.
Scheibenbogen, C., Weyers, I., Ruiter, D. J., Willhauck, M., Bittinger, A., Keilholz, U. (1996) Expression of gp100 in melanoma metastases resected before and after treatment with IFN-Ī± and IL-2. J. Immunother. 19, 375ā380.
de Vries, T. J., Fourkour, A., Wobbes, T., Verkroost, G., Ruiter, D. J., and van Muijen, G. N. Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions. Cancer Res. 57, 3223ā3229.
Lehmann, F., Marchand, M., Hainaut, P., et al. (1995) Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection. Eur. J. Immunol. 25, 340ā347.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2004 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Riker, A.I. (2004). Isolation and Culture of Melanoma Cell Lines. In: Langdon, S.P. (eds) Cancer Cell Culture. Methods in Molecular Medicineā¢, vol 88. Humana Press. https://doi.org/10.1385/1-59259-406-9:93
Download citation
DOI: https://doi.org/10.1385/1-59259-406-9:93
Publisher Name: Humana Press
Print ISBN: 978-1-58829-079-3
Online ISBN: 978-1-59259-406-1
eBook Packages: Springer Protocols